Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brentuximab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02254239
What this trial is testing

Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
Mayo Clinic 10
Testing effectiveness (Phase 2)Ended earlyNCT02096042
What this trial is testing

Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 1
Post-approval studies (Phase 4)Looking for participantsNCT06831370
What this trial is testing

Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Who this might be right for
Hodgkin Lymphoma
Takeda 124
Testing effectiveness (Phase 2)Study completedNCT01657331
What this trial is testing

Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)

Who this might be right for
Hodgkin LymphomaAnaplastic Large Cell Lymphoma
Columbia University 65
Testing effectiveness (Phase 2)Ended earlyNCT02689219
What this trial is testing

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

Who this might be right for
Germ Cell TumorsTestis CancerTesticular Cancer+2 more
Nabil Adra 18
Early research (Phase 1)Study completedNCT02164006
What this trial is testing

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients

Who this might be right for
Hodgkin's Lymphoma
TG Therapeutics, Inc. 16
Not applicableNot Yet RecruitingNCT07467317
What this trial is testing

BV-CHP Real-life and Biological Evidences in Patients With sALCL

Who this might be right for
Anaplastic Large Cell Lymphoma
Fondazione Italiana Linfomi - ETS 100
Not applicableLooking for participantsNCT07624838
What this trial is testing

Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain

Who this might be right for
CD30-Positive Peripheral T-Cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 100
Testing effectiveness (Phase 2)UnknownNCT04378647
What this trial is testing

BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant

Who this might be right for
Hodgkin Lymphoma, Adult
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 150
Testing effectiveness (Phase 2)Study completedNCT01393717
What this trial is testing

Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
City of Hope Medical Center 57
Testing effectiveness (Phase 2)WithdrawnNCT01616680
What this trial is testing

Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host Disease
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Testing effectiveness (Phase 2)Looking for participantsNCT04745949
What this trial is testing

PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy

Who this might be right for
Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell LymphomaAnn Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell LymphomaAnn Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma+1 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02729961
What this trial is testing

Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-PositiveCD30-Positive Neoplastic Cells PresentSystemic Anaplastic Large Cell Lymphoma
University of Washington
Testing effectiveness (Phase 2)WithdrawnNCT04334174
What this trial is testing

Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas

Who this might be right for
T Cell Lymphoma
University of Kansas Medical Center
Post-approval studies (Phase 4)Study completedNCT01909934
What this trial is testing

Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Who this might be right for
Lymphoma
Takeda 50
Testing effectiveness (Phase 2)Study completedNCT00848926
What this trial is testing

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

Who this might be right for
Disease, Hodgkin
Seagen Inc. 102
Early research (Phase 1)Study completedNCT02822586
What this trial is testing

TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome

Who this might be right for
Mycosis FungoidesSézary Syndrome
Virginia Commonwealth University 5
Testing effectiveness (Phase 2)Study completedNCT02398240
What this trial is testing

Brentuximab for Newly Diagnosed Hodgkin Disease

Who this might be right for
Hodgkin Lymphoma
Mitchell Cairo 40
Testing effectiveness (Phase 2)Study completedNCT03198689
What this trial is testing

Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Not applicableStudy completedNCT07171827
What this trial is testing

Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Who this might be right for
Anti-CD30BrentuximabDoxorubicin+4 more
Helwan University 60
Next Page
31